O-(2-(¹⁸F)fluoroethyl)-L-tyrosine PET for the differentiation of tumour recurrence from late pseudoprogression in glioblastoma

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):238-239. doi: 10.1136/jnnp-2017-317155. Epub 2018 Apr 28.

Affiliations

¹ Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
² Institute of Diagnostic Radiology, University Hospital Würzburg, Würzburg, Germany.
³ Department of Neurosurgery, University Hospital Würzburg, Würzburg, Germany.
⁴ Department of Neuropathology, University Hospital Würzburg, Würzburg, Germany.

PMID: 29705720
DOI: 10.1136/jnnp-2017-317155

No abstract available

Keywords: neurooncology; pet, ligand studies.

Publication types

Letter

MeSH terms

Adult
Aged
Brain Neoplasms / diagnostic imaging*
Brain Neoplasms / pathology*
Diagnosis, Differential
Female
Glioblastoma / diagnostic imaging*
Glioblastoma / pathology*
Humans
Male
Middle Aged
Neoplasm Recurrence, Local / diagnosis*
Positron-Emission Tomography*
Retrospective Studies
Tyrosine / analogs & derivatives
Young Adult

Substances

O-(2-fluoroethyl)tyrosine
Tyrosine